Bcl-2 regulates activation of apoptotic proteases in a cell-free system

Sabina C. Cosulich, Stephen Green, Paul R. Clarke (Lead / Corresponding author)

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background: Apoptosis plays an important role in the normal development and homeostasis of metazoans. Aberrations in this process have been implicated in several major human diseases, but its molecular mechanism is poorly understood. In animals as diverse as humans and nematodes, the Bcl-2 oncoprotein prevents or delays apoptosis, whereas proteases of the interleukin-1 β-converting enzyme (ICE) family are required, suggesting that they are components of a conserved mechanism controlling the onset of apoptosis. Results: A cell-free system produced from Xenopus laevis eggs reproduces nuclear events characteristic of apoptosis after a lag phase. We have used this system to define the temporal sequence of biochemical events and to examine the relationship between Bcl-2 and apoptotic proteases. Bcl-2 prevents apoptotic chromatin condensation and DNA cleavage, but only when added prior to the activation of a protease which has characteristics similar to the Ced-3 sub-family of ICE-like proteases and which cleaves poly(ADP-ribose) polymerase (PARP). Bcl-2 attenuates activation of this protease, an effect that does not require de novo protein synthesis or the presence of intact nuclei. The Cap-3-related protease CPP-32 is cleaved during the late stages of apoptosis in this system and after PARP cleavage. Generation of CPP-32-cleaving activity is inhibited by Bcl-2. Conclusions: These experiments provide direct biochemical evidence that Bcl-2 protects against apoptosis, at least in part, by regulating the activation of a series of apoptotic proteases that cleave PARP and other substrates. This cell-free system provides a useful biochemical model for analyzing the molecular mechanism controlling the activation of these proteases.

Original languageEnglish
Pages (from-to)997-1005
Number of pages9
JournalCurrent Biology
Volume6
Issue number8
DOIs
Publication statusPublished - 1 Aug 1996

Fingerprint

cell free system
Cell-Free System
Peptide Hydrolases
proteinases
Chemical activation
Apoptosis
apoptosis
Poly(ADP-ribose) Polymerases
NAD ADP-ribosyltransferase
Caspase 1
interleukin-1
DNA Cleavage
Molecular Models
Oncogene Proteins
Xenopus laevis
molecular models
Eggs
Chromatin
enzymes
Aberrations

Cite this

Cosulich, Sabina C. ; Green, Stephen ; Clarke, Paul R. / Bcl-2 regulates activation of apoptotic proteases in a cell-free system. In: Current Biology. 1996 ; Vol. 6, No. 8. pp. 997-1005.
@article{cf61bfc513714d858188d557b120361d,
title = "Bcl-2 regulates activation of apoptotic proteases in a cell-free system",
abstract = "Background: Apoptosis plays an important role in the normal development and homeostasis of metazoans. Aberrations in this process have been implicated in several major human diseases, but its molecular mechanism is poorly understood. In animals as diverse as humans and nematodes, the Bcl-2 oncoprotein prevents or delays apoptosis, whereas proteases of the interleukin-1 β-converting enzyme (ICE) family are required, suggesting that they are components of a conserved mechanism controlling the onset of apoptosis. Results: A cell-free system produced from Xenopus laevis eggs reproduces nuclear events characteristic of apoptosis after a lag phase. We have used this system to define the temporal sequence of biochemical events and to examine the relationship between Bcl-2 and apoptotic proteases. Bcl-2 prevents apoptotic chromatin condensation and DNA cleavage, but only when added prior to the activation of a protease which has characteristics similar to the Ced-3 sub-family of ICE-like proteases and which cleaves poly(ADP-ribose) polymerase (PARP). Bcl-2 attenuates activation of this protease, an effect that does not require de novo protein synthesis or the presence of intact nuclei. The Cap-3-related protease CPP-32 is cleaved during the late stages of apoptosis in this system and after PARP cleavage. Generation of CPP-32-cleaving activity is inhibited by Bcl-2. Conclusions: These experiments provide direct biochemical evidence that Bcl-2 protects against apoptosis, at least in part, by regulating the activation of a series of apoptotic proteases that cleave PARP and other substrates. This cell-free system provides a useful biochemical model for analyzing the molecular mechanism controlling the activation of these proteases.",
author = "Cosulich, {Sabina C.} and Stephen Green and Clarke, {Paul R.}",
year = "1996",
month = "8",
day = "1",
doi = "10.1016/S0960-9822(02)00644-9",
language = "English",
volume = "6",
pages = "997--1005",
journal = "Current Biology",
issn = "0960-9822",
publisher = "Elsevier",
number = "8",

}

Bcl-2 regulates activation of apoptotic proteases in a cell-free system. / Cosulich, Sabina C.; Green, Stephen; Clarke, Paul R. (Lead / Corresponding author).

In: Current Biology, Vol. 6, No. 8, 01.08.1996, p. 997-1005.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bcl-2 regulates activation of apoptotic proteases in a cell-free system

AU - Cosulich, Sabina C.

AU - Green, Stephen

AU - Clarke, Paul R.

PY - 1996/8/1

Y1 - 1996/8/1

N2 - Background: Apoptosis plays an important role in the normal development and homeostasis of metazoans. Aberrations in this process have been implicated in several major human diseases, but its molecular mechanism is poorly understood. In animals as diverse as humans and nematodes, the Bcl-2 oncoprotein prevents or delays apoptosis, whereas proteases of the interleukin-1 β-converting enzyme (ICE) family are required, suggesting that they are components of a conserved mechanism controlling the onset of apoptosis. Results: A cell-free system produced from Xenopus laevis eggs reproduces nuclear events characteristic of apoptosis after a lag phase. We have used this system to define the temporal sequence of biochemical events and to examine the relationship between Bcl-2 and apoptotic proteases. Bcl-2 prevents apoptotic chromatin condensation and DNA cleavage, but only when added prior to the activation of a protease which has characteristics similar to the Ced-3 sub-family of ICE-like proteases and which cleaves poly(ADP-ribose) polymerase (PARP). Bcl-2 attenuates activation of this protease, an effect that does not require de novo protein synthesis or the presence of intact nuclei. The Cap-3-related protease CPP-32 is cleaved during the late stages of apoptosis in this system and after PARP cleavage. Generation of CPP-32-cleaving activity is inhibited by Bcl-2. Conclusions: These experiments provide direct biochemical evidence that Bcl-2 protects against apoptosis, at least in part, by regulating the activation of a series of apoptotic proteases that cleave PARP and other substrates. This cell-free system provides a useful biochemical model for analyzing the molecular mechanism controlling the activation of these proteases.

AB - Background: Apoptosis plays an important role in the normal development and homeostasis of metazoans. Aberrations in this process have been implicated in several major human diseases, but its molecular mechanism is poorly understood. In animals as diverse as humans and nematodes, the Bcl-2 oncoprotein prevents or delays apoptosis, whereas proteases of the interleukin-1 β-converting enzyme (ICE) family are required, suggesting that they are components of a conserved mechanism controlling the onset of apoptosis. Results: A cell-free system produced from Xenopus laevis eggs reproduces nuclear events characteristic of apoptosis after a lag phase. We have used this system to define the temporal sequence of biochemical events and to examine the relationship between Bcl-2 and apoptotic proteases. Bcl-2 prevents apoptotic chromatin condensation and DNA cleavage, but only when added prior to the activation of a protease which has characteristics similar to the Ced-3 sub-family of ICE-like proteases and which cleaves poly(ADP-ribose) polymerase (PARP). Bcl-2 attenuates activation of this protease, an effect that does not require de novo protein synthesis or the presence of intact nuclei. The Cap-3-related protease CPP-32 is cleaved during the late stages of apoptosis in this system and after PARP cleavage. Generation of CPP-32-cleaving activity is inhibited by Bcl-2. Conclusions: These experiments provide direct biochemical evidence that Bcl-2 protects against apoptosis, at least in part, by regulating the activation of a series of apoptotic proteases that cleave PARP and other substrates. This cell-free system provides a useful biochemical model for analyzing the molecular mechanism controlling the activation of these proteases.

UR - http://www.scopus.com/inward/record.url?scp=0030220462&partnerID=8YFLogxK

U2 - 10.1016/S0960-9822(02)00644-9

DO - 10.1016/S0960-9822(02)00644-9

M3 - Article

C2 - 8805330

AN - SCOPUS:0030220462

VL - 6

SP - 997

EP - 1005

JO - Current Biology

JF - Current Biology

SN - 0960-9822

IS - 8

ER -